Millennium Silver Corp

Swiss Pharma Giants Pour $27 Billion into U.S. Operations Following Tariff Agreement

- Swiss companies invested $27 billion in the United States between January and April 2025, according to an internal Swiss-American Chamber of Commerce email reported by NZZ am Sonntag. - The investment surge follows a November 14 agreement reducing U.S. punitive tariffs on Swiss goods from 39% to 15%, with Swiss firms pledging $200 billion over five years. - Novartis announced a biomedical research center in San Diego and a cancer-drug production facility in Texas, while Roche is expanding manufacturing output in North Carolina. - Medical technology company Ypsomed is building a new factory in the U.S., and shipping group MSC is establishing a new North American headquarters in Miami.